ClinicalTrials.Veeva

Menu

The Effect of Administering a Small Dose of Glucose During Cesarean Section

N

Nagoya City University

Status

Unknown

Conditions

Cesarean Section

Treatments

Drug: acetate Ringer's solution containing 1% glucose
Drug: acetate Ringer's solution containing no glucose
Drug: administer acetate Ringer's solution

Study type

Interventional

Funder types

Other

Identifiers

NCT01706341
NCU-573

Details and patient eligibility

About

The purpose of this study is to investigate the effect of administering a small dose of glucose on the pregnant women and their neonates during cesarean section. We investigate the safety and efficacy of use of a glucose-containing solution for the pregnant women and the neonates.

Full description

Rapid infusion of large amount of glucose is associated with fetal hyperglycemia, hyperinsulinemia, and neonatal hypoglycemia. However, the effect of small dose of glucose is unclear. We conducted a pilot study of small dose of glucose. We investigated the effect of a glucose-containing fluid on the blood sugar of the umbilical artery. We found that in the case of no-glucose-containing fluid, there were some cases in which umbilical arterial concentration of glucose was less than 50 mg/dl, which might cause neonatal hypoglycemia. In addition, in the case of 1%-glucose-containing fluid, mean umbilical arterial concentration of glucose was 97 mg/dl.

The purpose of this study is to investigate the effect of administering a small dose of glucose on the pregnant women and their neonates during cesarean section. We investigate the safety and efficacy of use of a glucose-containing solution for the pregnant women and the neonates.

Enrollment

40 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing cesarean section who met the criteria of the American Society of Anesthesiologists physical status of 1-2

Exclusion criteria

  • ASA physical status >=3, Obesity (BMI>35), Height>=175cm, Weight>=80Kg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

acetate Ringer's solution
Active Comparator group
Description:
Administering acetate Ringer's solution that contains no glucose as an initial infusion A total infusion volume of acetate Ringer's solution is 1500ml
Treatment:
Drug: administer acetate Ringer's solution
Drug: acetate Ringer's solution containing no glucose
acetate Ringer's solution with 1% glucose
Active Comparator group
Description:
Administering the acetate Ringer's solution that contains 1% glucose as an initial infusion A total infusion volume of the acetate Ringer's solution containing 1% glucose is 1500ml (containing 15g of glucose)
Treatment:
Drug: administer acetate Ringer's solution
Drug: acetate Ringer's solution containing 1% glucose

Trial contacts and locations

1

Loading...

Central trial contact

Yoshihito Fujita, MD. PhD.; Saya Yoshizawa, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems